Analysis of Outcome Measures in Patients with a Fragility Fracture Treated with Forteo and Supplemented with Prescriptive Vitamin D
Presentation Type
Oral and/or Visual Presentation
Presenter Major(s)
Physician Assistant Studies
Mentor Information
Theresa Bacon-Baguley, bacon-bt@gvsu.edu
Department
Physician Assistant Studies
Location
Kirkhof Center 2201
Start Date
13-4-2011 3:00 PM
End Date
13-4-2011 3:30 PM
Keywords
Health, Illness, and Healing
Abstract
Osteoporosis is defined by the National Osteoporosis Foundation as a disease characterized by low bone mass and structural deterioration of bone tissue, leading to bone fragility and increased susceptibility to fractures. The cause of osteoporosis is linked to a disorder in the normal bone metabolism. Bone tissue normally undergoes a cyclical process of breakdown (bone resorption) followed by bone formation. Disruption of this cycle can lead to a low bone mineralization and osteoporosis. Both calcium and vitamin D play a crucial role in bone formation. Without sufficient vitamin D levels, calcium cannot be absorbed in the GI tract and bone mineralization decreases. One of the treatments for osteoporosis is Forteo@ (teriparatide). The purpose of this study was to determine the change in bone mineral density and physiologic markers of bone metabolism, in those individuals who were treated with Forteo@ for osteoporosis and were also prescribed vitamin D based on their pretreatment vitamin D levels.
Analysis of Outcome Measures in Patients with a Fragility Fracture Treated with Forteo and Supplemented with Prescriptive Vitamin D
Kirkhof Center 2201
Osteoporosis is defined by the National Osteoporosis Foundation as a disease characterized by low bone mass and structural deterioration of bone tissue, leading to bone fragility and increased susceptibility to fractures. The cause of osteoporosis is linked to a disorder in the normal bone metabolism. Bone tissue normally undergoes a cyclical process of breakdown (bone resorption) followed by bone formation. Disruption of this cycle can lead to a low bone mineralization and osteoporosis. Both calcium and vitamin D play a crucial role in bone formation. Without sufficient vitamin D levels, calcium cannot be absorbed in the GI tract and bone mineralization decreases. One of the treatments for osteoporosis is Forteo@ (teriparatide). The purpose of this study was to determine the change in bone mineral density and physiologic markers of bone metabolism, in those individuals who were treated with Forteo@ for osteoporosis and were also prescribed vitamin D based on their pretreatment vitamin D levels.